Nathan D. Mathewson
0000-0002-8895-2609
Publication & Citation Trends
Publications
0 total
Abstract 1847: Engineered cell surface tag-targeted IL-2 and IL-21 selectively and safely enhance CAR-T anti-tumor activity via different mechanisms
Cited by 0
Semantic Scholar
DIPG-19. BAF COMPLEX PERTURBATION AS A NOVEL THERAPEUTIC OPPORTUNITY IN H3K27M PEDIATRIC GLIOMA OA
Cited by 0
Semantic Scholar
BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma OA
Cited by 46
Semantic Scholar
Systematic Interrogation of Tumor Cell Resistance to Chimeric Antigen Receptor T-cell Therapy in Pancreatic Cancer OA
Cited by 21
Semantic Scholar
43P Development of a production process to generate CD8+ T cell-enriched tumor-nfiltrating lymphocyte (TIL) products with increased cytotoxic potential for the treatment of patients with solid cancers OA
Cited by 0
Semantic Scholar
Selective Support of CAR-T Cell Therapies By Cis-Targeted IL-2 or IL-21 Cytokines Results in Enhanced Anti-Tumor Activity OA
Cited by 1
Semantic Scholar
Abstract 561: CAR-targeted IL-2 drives selective CAR-T cell expansion and improves anti-tumor efficacy
Cited by 1
Semantic Scholar
OTME-7. Cancer - immune cell interactions drive transitions to mesenchymal-like state in glioblastoma OA
Cited by 0
Semantic Scholar
Research Topics
Immune Cell Function and Interaction
(69)
CAR-T cell therapy research
(55)
Cancer Immunotherapy and Biomarkers
(51)
Immunotherapy and Immune Responses
(23)
Glioma Diagnosis and Treatment
(22)
Affiliations
Broad Institute
Boston University
Brigham and Women's Hospital
Harvard University
Grinnell College